Lifestyle
What Happens When You Stop Taking GLP-1s
Last clinically reviewed: September 24, 2026 by Dr. Prajeet Reddy, MD (Medical Director)

This guide covers what usually happens when you stop a GLP-1 medication for weight management — semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro) or liraglutide (Saxenda) — and the steps that help you hold onto as much of your progress as possible. Use it alongside a conversation with your prescriber, and don't change or stop your medication based on this page alone.
The Most Important Thing to Know
Obesity is a long-term medical condition, much like high blood pressure or diabetes. GLP-1 medications work while you take them, partly by turning down appetite and hunger signals in the brain. When the medication stops, those signals gradually return to where they were — so appetite comes back and some weight tends to return.[6]
This is a biological response, not a sign of weak willpower or personal failure. And how you stop — and what you put in place around stopping — makes a real difference in how much progress you keep.
What Usually Happens to Your Weight
Across the major studies, people regained about two-thirds of the weight they had lost within roughly a year of stopping, even when they kept trying to eat well.[1][5]
| Medication | Weight lost on treatment | After stopping |
|---|---|---|
| Semaglutide (STEP 1 extension) | About 17% | Regained about two-thirds within a year; ended about 6% below starting weight[1] |
| Tirzepatide (SURMOUNT-4) | About 21% | Regained about 14% over the next year; still about 10% below starting weight[2] |
| Liraglutide | Smaller losses | Smaller regain in pounds, same overall pattern[5] |
A few things to keep in mind:
- Regain usually starts within the first 8 to 12 weeks after stopping and is fastest early on. This early window is when your plan matters most.[7]
- Results vary a lot from person to person. A minority of people keep most of their loss, and a few keep losing. There's currently no reliable way to predict in advance who will do which.
- Health numbers tend to follow weight. Blood pressure, blood sugar and cholesterol often improve during treatment and can drift back toward earlier levels as weight returns — another reason to keep monitoring after stopping.[1]
Why People Stop — and Why It Matters for the Plan
People stop GLP-1s for many reasons: cost or insurance changes, supply problems, side effects, pregnancy planning, or reaching a goal. The reason often shapes the best next step. If side effects are the problem, a lower dose may be an option instead of stopping entirely. If you're planning a pregnancy, timing matters — see GLP-1s and pregnancy. Bring your specific reason to your prescriber so the plan fits your situation.
Options Besides Stopping Completely
Stopping isn't all-or-nothing. Ask your prescriber whether one of these fits you:
- Stay on the lowest dose that keeps you stable. Continuing at a reduced dose protects weight loss better than stopping, even if it isn't quite as strong as the full dose. In the SURMOUNT-MAINTAIN trial, 78% of people who stayed on their full tirzepatide dose kept at least 80% of their weight loss, versus 42% who stepped down to 5 mg and 10% who switched to placebo.[3]
- Space out doses under medical guidance.
- Taper slowly rather than stopping abruptly, so your body adjusts more gradually.
Whether a gradual taper beats simply stopping hasn't yet been proven in head-to-head trials, but many obesity specialists favor a stepwise approach because it avoids a sudden loss of appetite control.[6][7] Your prescriber's judgment and your preferences both matter here. More on staying on treatment: maintenance dosing.
A Practical Plan for Tapering or Stopping
Build every plan with your prescriber. A common, sensible framework:
- Don't rush the taper the moment you reach your goal. Spend a stretch of time stable at your effective dose first, so your new eating and activity habits are well established before anything changes.
- Step down gradually — a lower dose or less frequent dosing — over at least several months rather than all at once.
- Weigh yourself regularly, on a set day each week, so you catch regain early instead of months later.
- Agree on a restart threshold in advance. Many clinicians suggest that if weight climbs back more than about 5%, it's time to revisit the dose or the medication. Knowing the plan ahead of time removes the guesswork.
- Keep your follow-up visits, especially in the first 3 months after stopping, and keep an eye on blood pressure and blood sugar if those had improved.
If you do restart after several weeks off, expect to begin at a lower dose and step back up — returning straight to your old dose often causes severe nausea. See missed GLP-1 doses.
What Helps You Keep Your Progress
These habits won't fully cancel out the body's pull toward regain, but the evidence supports them, and they're within your control.
Move your body, and build muscle. This is the best-studied habit for keeping weight off. In one clinical trial, people who combined exercise with a GLP-1 kept far more of their weight off a full year after all treatment stopped than those who used the medication without structured exercise.[4] Aim for:
- At least 150 minutes a week of moderate activity (brisk walking counts); more is better for keeping weight off
- Strength training 2 to 3 times a week — GLP-1 weight loss includes some muscle, and preserving it keeps your metabolism healthier
More: exercise on GLP-1s.
Protect muscle with protein. Include a good protein source at every meal as you transition off the medication.
Eat in a way that fills you up on fewer calories. Favor vegetables, fruit, whole grains, beans and other high-fiber, less-processed foods; limit sugary drinks and highly processed snacks. Regular meal times and a regular breakfast are habits shared by people who keep weight off long-term. More: what to eat on a GLP-1.
Keep tracking. Self-monitoring — your weight, your food, your activity — is one of the most consistent features of people who maintain weight loss. Limiting screen time and planning ahead for high-risk situations also help.
Get support. Emotional and stress-related eating is common. Counseling approaches such as cognitive behavioral therapy, a dietitian, or a structured program can make the transition easier.
When to Call Your Prescriber
- Weight climbing back faster than expected, or past the threshold you agreed on
- Symptoms that had improved coming back — higher blood sugar, rising blood pressure, worsening reflux or sleep apnea
- Hunger or food thoughts becoming hard to manage
- Any question about restarting, lowering, or switching medication
The Short Version
Some weight regain after stopping a GLP-1 is expected — it reflects biology, not failure. Stepping down gradually or staying on a lower dose, strength training, eating protein- and fiber-rich foods, weighing yourself regularly, and staying in touch with your prescriber all help you keep more of what you achieved. If weight does return, restarting or adjusting medication is a reasonable, evidence-based option — not a setback to be ashamed of.
Frequently asked questions
Will I gain the weight back if I stop Wegovy or Zepbound?
Most people regain some weight. In the major trials, people regained about two-thirds of the weight they had lost within roughly a year of stopping, even while trying to eat well. Results vary a lot: a minority keep most of their loss, and there's no reliable way to predict in advance who will. Regain reflects appetite signals returning — it's biology, not a lack of willpower.
How fast does weight come back after stopping a GLP-1?
Regain usually starts within the first 8 to 12 weeks after the last dose and is fastest early on. That's why the first few months after stopping are when your plan matters most: regular weigh-ins, strength training, protein at every meal, and a pre-agreed point at which you and your prescriber revisit the medication.
Should I taper off a GLP-1 or stop all at once?
Many obesity specialists favor a gradual step-down — a lower dose or less frequent dosing over several months — to avoid a sudden loss of appetite control, though head-to-head trials haven't yet proven that tapering beats stopping. Staying on a lower maintenance dose does protect weight loss better than stopping: in the SURMOUNT-MAINTAIN trial, 42% of people who stepped down to tirzepatide 5 mg kept at least 80% of their loss, versus 10% of those switched to placebo.
Can I restart my GLP-1 if the weight comes back?
Yes — restarting or adjusting medication is a reasonable, evidence-based option, not a setback. Agree on a restart threshold with your prescriber in advance (many suggest revisiting treatment if weight climbs back more than about 5%). If you restart after several weeks off, expect to begin at a lower dose and step back up to avoid stomach side effects.
Sources
- Weight Regain and Cardiometabolic Effects After Withdrawal of Semaglutide: The STEP 1 Trial Extension — Wilding et al., Diabetes Obes Metab 2022
- Continued Treatment With Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4) — Aronne et al., JAMA 2024
- Tirzepatide for Maintenance of Bodyweight Reduction in People With Obesity (SURMOUNT-MAINTAIN) — Horn et al., Lancet 2026
- Healthy Weight Loss Maintenance With Exercise, GLP-1 Receptor Agonist, or Both Combined Followed by One Year Without Treatment — Jensen et al., EClinicalMedicine 2024
- Discontinuing GLP-1 Receptor Agonists and Body Habitus: A Systematic Review and Meta-Analysis — Berg et al., Obesity Reviews 2025
- Obesity and Weight Management: ADA Standards of Care in Diabetes — 2026
- Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation — Damhof et al., Diabetes Obes Metab 2026
This article is for education and does not replace your prescriber’s instructions or the FDA Medication Guide that comes with your medication. Clinical content reviewed by Dr. Prajeet Reddy, MD, Medical Director (Cyane Medical Group California PC).
$29/mo membership — the lowest in GLP-1 telehealth. No contracts.